Takeda Announces Significant Job Cuts, Centered on Cambridge R&D

GLP-1 Drugs: The Unexpected Battle Against Addiction

Closing Bell Insights: Navigating Pfizer, Agribusiness, and Gold Miners as the Market Winds Down

Essential Medicines: DRAP Dispels Price Hike Rumors Amid Global Uncertainty

Eli Lilly's Cancer Revolution: How Loxo Oncology Reshaped an Empire

The Unforeseen Ripple: How Trump's Drug Pricing Push Could Have Raised Global Costs

India's Rupee Hits New Low: A Double-Edged Sword for the Economy

Navigating the Future of Health: A Deep Dive into Nomura Healthcare Fund's Q4 2025 Insights

Deepening Roots: India's Manufacturing Dreams and Global Pharma's Embrace

When Geopolitics Hits Home: The Unsettling Shadow of an Iran Conflict on Our Medicine Cabinet

The Gene Therapy Race: Is America Losing Ground to China's Rapid Advance?

The Dawn of a New Era: Accessible Obesity Treatment for All

The Persistent Echo: Trump's Most Favored Nation Policy Still Shapes Drug Pricing Debates

Five Crucial Stocks to Watch as We Kick Off the Trading Week

The Shadow Side of Breakthroughs: A Tragic Ozempic Lawsuit Unveils Concerns Over Patient Safety

A Glimmer of Hope for Kidney Disease: Vertex's Breakthrough in IgA Nephropathy

A New Chapter in Obesity Care: Novo Nordisk and Hims & Hers Team Up for Broader Access

Olema Pharmaceuticals Stock Takes a Dive: What Sparked the Sudden Plunge?

A Critical Voice Departs: Dr. Vinay Prasad's Resignation From FDA Advisory Role

The Price of Life: Will South Africa Gain Access to Gilead's Breakthrough HIV Drug?

The Persistent Ache: Why Affordable Drug Prices Remain an Elusive Dream for Americans

Virginia's Bold Move: A New Era for Prescription Drug Affordability

A Major Setback: FDA Halts uniQure's Huntington's Gene Therapy Trial

GSK's Bold Move: A $1.8 Billion Bet on the Future of Pulmonary Hypertension Treatment

The Final Word: Navigating Pharma's Powerhouse and Gold's Gleam in Today's Markets

A New Chapter Unfolds: India and Brazil Forge Stronger Ties, Eyeing Critical Minerals and a Bilateral Trade Boom

Is India-US Trade Deal a 'Trap'? Kharge Demands Transparency on Critical Agreement

Pfizer's Recent Rally: A Fleeting Illusion or Sustainable Recovery?

A Game-Changer on the Horizon: Disc Medicine's Bitopertin and the FDA's Looming Decision

Beyond the Headlines: Uncovering Resilience in a Tumbling Market

Wegovy in Vials? Novo Nordisk's Strategic Shift to Boost Supply and Challenge Eli Lilly

Viking Therapeutics Rockets Skyward: Is Their Obesity Drug the Next Market Game-Changer?

Unpacking Trump's Vision for 340B: A Pilot Program's Complex Ripples

Servier's Bold Move: India Becomes Global Nerve Center for Critical Single-Pill Drugs, Eyeing €500 Million in Exports

AstraZeneca's Stellar Q4 Performance: Cancer Drugs Propel Growth and Investor Confidence

GlaxoSmithKline's 2025 Year-End Roar: A Story of Impressive Growth and Strong Financials

Vertex's Pivotal Moment: Beyond CF, What to Expect from Q4 Earnings

Important Health Advisory: Understanding the Latest Medication Recall

Biogen Delivers a Welcome Surprise: Robust Profit Forecast Exceeds Expectations